Literature DB >> 6152975

Effects of streptozotocin in the WDHA syndrome not amenable to radical surgery.

G Biliotti1, C Masi, M Macchini, T Bani Sacchi, G Bartolini, P Stefani, F Tonelli.   

Abstract

Two cases of Verner-Morrison syndrome due to pancreatic carcinoma were treated H. h streptozotocin (STZ) according to the schedule suggested by the Division of Cancer Treatment of the National Cancer Institute. In both patients the drug caused a remission of the WDHA syndrome: therefore, this finding seems to recommend such treatment when the syndrome is not amenable to radical surgery. Renal toxicity is, however, an important limitation. It occurs mostly when STZ is administered by iv infusion. In one of the patients, after a serious impairment of renal function caused by STZ, prednisone controlled the syndrome for a long period of time.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6152975     DOI: 10.1007/BF03348279

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  8 in total

1.  Letter: Treatment of "pancreatic cholera".

Authors:  S R Siegel; F M Muggia
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

2.  Pancreatic cholera: benefical effects of treatment with streptozotocin.

Authors:  C R Kahn; A G Levy; J D Gardner; J V Miller; P Gorden; P S Schein
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

3.  Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients.

Authors:  L E Broder; S K Carter
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

4.  Watery diarrhea and hypokalemia due to nonbeta-islet cell hyperplasia of the pancreas.

Authors:  W H Jacobs; P Halperin; F A Mantz
Journal:  Am J Gastroenterol       Date:  1972-04       Impact factor: 10.864

5.  Islet cell tumor of the pancreas with reversible watery diarrhea and achylorhydraia.

Authors:  I N Marks; S Bank; J H Louw
Journal:  Gastroenterology       Date:  1967-04       Impact factor: 22.682

6.  Recognition and management of the diarrheal syndrome caused by nonbeta islet cell tumors of the pancreas.

Authors:  A R Kraft; R K Tompkins; R M Zollinger
Journal:  Am J Surg       Date:  1970-02       Impact factor: 2.565

7.  Hepatic inactivation of vasoactive intestinal peptide in man and dog.

Authors:  A M Ebeid; J Escourrou; P B Soeters; P Murray; J E Fischer
Journal:  Ann Surg       Date:  1978-07       Impact factor: 12.969

8.  Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.

Authors:  R F Gagel; M E Costanza; R A DeLellis; R A Norton; S R Bloom; H H Miller; A Ucci; L Nathanson
Journal:  Arch Intern Med       Date:  1976-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.